MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-10664

  1. 3,214 Posts.
    lightbulb Created with Sketch. 951
    @Blackswans thank you, much appreciated. If any other bits come to mind as interesting, please don't hold back from sharing, because all of that, certainly was.

    Interesting (my take) that regenerative therapy seems to be on the nose (playing god..?) but cell-based therapy is now (thank you vaccines, etc) acceptable and in wide use.

    I wonder... if certain flags in the political spheres (and therefore the FDA) get setoff by one, and not the other....

    Now to talk Itescu into a real label change. I think he's always loved it being regenerative, so it may be hard for him...
    Last edited by 6151: 22/08/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.